Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has filed a patent application to protect the recently developed Optimer binder sequences for novel applications.

Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for customers working in laboratory technology, analysis, biotechnology, and environmental quality.

Collaboration leverages cutting-edge digital platform to streamline development and manufacturing activities and speed patient access to life-changing treatments.

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.

Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory.

Sterilis Solutions and Polycarbin proudly announce their strategic partnership aimed at enhancing sustainability in laboratory waste management.

First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.

As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma